Feb 26, 2016

The Groundbreaking Discoveries of Rita Levi-Montalcini and Stanley Cohen: The Birth of Growth Factors

Introduction: Overcoming Adversity to Make Scientific History

Rita Levi-Montalcini’s journey to scientific acclaim is a story of resilience and brilliance against the backdrop of political and personal challenges. After earning her medical degree from the University of Turin in 1938, Levi-Montalcini's promising career was suddenly stifled by Mussolini's 1939 decree, which barred non-Aryan Italians from pursuing professional careers. Undeterred, she set up a small laboratory in her home and began independent research, drawing inspiration from the work of Viktor Hamburger, a renowned scientist in the field of developmental biology. Her pioneering research laid the foundation for groundbreaking discoveries that would forever change our understanding of cellular growth and development.

Discovering Nerve Growth Factor (NGF)

In 1947, Levi-Montalcini took her research to new heights when she joined Viktor Hamburger at Washington University in St. Louis, Missouri. Here, she studied nerve tissue growth, continuing her focus on chick embryos. In 1948, she made a pivotal discovery: when a piece of a mouse tumor was grafted onto chick embryos with their wing buds removed, nerve growth was significantly stimulated in the surrounding tissue. This unexpected result marked the beginning of an entirely new field of research in neurobiology.

In 1953, Levi-Montalcini was joined by biochemist Stanley Cohen, who played a crucial role in isolating the active protein from the tumor tissue. Together, they identified and named the protein nerve growth factor (NGF). This discovery revealed that NGF is essential for the growth, maintenance, and survival of nerves in the peripheral nervous system (outside the brain and spinal cord), as well as for certain cholinergic nerves in the brain.

The Discovery of Epidermal Growth Factor (EGF)

Stanley Cohen continued to build on the discoveries he and Levi-Montalcini had made. In 1959, after moving to Vanderbilt University, Cohen isolated another significant growth factor from the NGF-containing tumor. This protein was found to stimulate the growth of the epidermal layer of skin and had a remarkable effect on newborn mice, causing them to open their eyes earlier than normal. Cohen named this newly discovered protein epidermal growth factor (EGF). The discovery of EGF, like NGF, revealed the immense potential of growth factors in regulating various biological processes.

Nobel Prize Recognition for Their Revolutionary Work

The groundbreaking work of Rita Levi-Montalcini and Stanley Cohen did not go unnoticed. In 1986, both scientists were awarded the Nobel Prize in Physiology or Medicine for their pioneering discoveries of growth factors. Their contributions have had an enduring impact on cell biology and medicine, further establishing the critical role of proteins in cellular development.

The Rise of Growth Factors: A Revolution in Cellular Biology

NGF was the first of approximately fifty growth-promoting agents identified in biological research. These growth factors are secreted by various tissues in the body and serve as signaling molecules between cells. They play a crucial role in stimulating cellular growth, replication, and differentiation (the process by which cells become specialized). Growth factors are not only present in humans but have also been identified in a wide range of organisms, including plants, insects, and vertebrates.

The discovery of growth factors has revolutionized medical treatments. These proteins are now used to treat a variety of conditions, including cancers, blood disorders, and cardiovascular diseases. One of the most well-known growth factors is erythropoietin (EPO), which is produced in the kidneys and stimulates the production of red blood cells. EPO’s impact extends beyond medicine, as it has also gained notoriety in the world of sports, where it is sometimes used as a blood doping agent to enhance performance, particularly in endurance sports like cycling.

Conclusion: A Legacy of Scientific Innovation

The work of Rita Levi-Montalcini and Stanley Cohen has left an indelible mark on the field of biology, with their discoveries shaping the way scientists understand cellular development and growth. From the identification of NGF and EGF to the broader implications of growth factors in medicine, their work continues to influence medical treatments and scientific research today. Their contributions not only exemplify the power of perseverance and collaboration but also serve as a testament to the transformative power of discovery in the life sciences.


Among the fifty-or-so growth-promoting factors that have been discovered since 1953, perhaps the most well known is erythropoietin (EPO), which stimulates red blood cell production. EPO has gained a notorious reputation as a blood-doping agent, increasing oxygen delivery to muscles, which enhances endurance performance.

No comments:

Post a Comment